期刊文献+

活动期类风湿关节炎患者血清人类软骨糖蛋白-39水平测定的意义 被引量:4

The significance of the determination of serum level of human cartilage glycoprotein 39 in patients with active rheumatoid arthritis
下载PDF
导出
摘要 目的研究活动期类风湿关节炎(RA)患者血清人类软骨糖蛋白-39(HC gp-39)的水平及意义。方法选取47例初诊活动期、42例非活动期RA患者和38名健康查体者,采用酶联免疫吸附试验(ELISA)测定血清HC gp-39水平,同时测定关节肿胀数(SJC)、关节压痛数(TJC)、红细胞沉降率(ESR)、C反应蛋白(CRP)、类风湿因子(RF)等相关实验室指标。结果活动期RA患者血清HC gp-39水平明显高于非活动期RA患者及正常对照者(P<0.01)。非活动期RA患者与正常对照者HC gp-39水平差异无统计学意义(P>0.05)。不同X线分期患者HC gp-39水平差异有统计学意义(P<0.05),不同关节功能分级时差异无统计学意义(P>0.05)。HCgp-39水平与SJC、TJC、ESR、CRP、关节X线分期呈正相关性(P<0.01),与年龄、病程、晨僵时间、RF、关节功能分级无明显相关性(P>0.05)。结论 HC gp-39在活动期RA患者血清中呈高水平表达,可作为反映疾病活动和RA患者出现骨侵蚀的有益预测指标。 Objective To investigate the determination of the serum level of human cartilage glycoprotein 39(HC gp-39) and its significance in patients with active rheumatoid arthritis(RA).Methods The serum HC gp-39 level was determined in 47 patients with active RA,42 patients with inactive RA and 38 healthy controls by enzyme-linked immunosorbent assay(ELISA).The swollen joint count(SJC),tender joint count(TJC),erythrocyte sedimentation rate(ESR),C reactive protein(CRP) and rheumatoid factor(RF) were determined.Results Serum HC gp-39 level in active RA patients was significantly higher than those in inactive RA patients and healthy controls(P0.01),but there was no significant difference between inactive RA patients and healthy controls(P0.05).HC gp-39 levels in different line X stages had statistical difference(P0.05),but HC gp-39 levels with different stages of joint function had no significant difference(P0.05).The serum HC gp-39 level was positively correlated with the SJC,TJC,ESR,CRP and line X stages(P0.01),but it had no obvious correlation with age,disease course,length of morning stiffness,RF and joint function stages(P0.05).Conclusions Serum HC gp-39 level increases significantly in active RA patients.It can be used as an indicator for disease activity and a valuable predictor of the progression of bone erosion.
出处 《检验医学》 CAS 北大核心 2010年第9期708-711,共4页 Laboratory Medicine
关键词 人类软骨糖蛋白-39 活动期 类风湿关节炎 Human cartilage glycoprotein 39 Active stage Rheumatoid arthritis
  • 相关文献

参考文献12

  • 1Arnett FC,Edworthy SM,Bloch DA,et al.The Am-erican Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis[J].Arthritis Rheum,1988,31(3):315-324.
  • 2类风湿关节炎诊治指南(草案)[J].中华风湿病学杂志,2003,7(4):250-254. 被引量:430
  • 3Hakala BE,White C,Recklies AD.Human cartilage gp-39,a major secretory product of articular chondrocytes and synovial cells,is a mammalian member of a chitinase protein family[J].J Biol Chem,1993,268(34):25803-25810.
  • 4Volck B,Price PA,Johansen JS,et al.YKL-40,a mammalian member of the chitinase family,is a matrix protein of specific granules in human neutrophils[J].Proc Assoc Am Physicians,1998,110(4):315-360.
  • 5Verheijden GF,Rijnders AW,Bos E,et al.Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis[J].Arthritis Rheum,1997,40(6):1115-1125.
  • 6Johansen JS,Krabbe KS,Moller K,et al.Circulating YKL-40 levels during human endotoxaemia[J].Clin Exp Immunol,2005,140(2):343-348.
  • 7Schmidt H,Johansen JS,Gehl J,et al.Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma[J].Cancer,2006,106(5):1130-1139.
  • 8Johansen JS,Jensen BV,Roslind A,et al.Is YKL-40 a new therapeutic target in cancer[J].Expert Opin Ther Targets,2007,11(2):219-234.
  • 9Vos K,Steenbakkers P,Miltenburg AM,et al.Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditions[J].Ann Rheum Dis,2000,59(7):544-548.
  • 10Harvey S,Weisman M,O′Dell J,et al.Chondrex:new marker of joint disease[J].Clin Chem,1998,44(3):509-516.

共引文献429

同被引文献44

  • 1邓小虎,黄烽.大动脉炎159例回顾性临床分析[J].中华风湿病学杂志,2006,10(1):39-43. 被引量:43
  • 2许荣,钟丽民,袁斌,周丽萍,何东林,候娜莉,李宁丽,王利,陈广洁,余奇文,张冬青.骨桥蛋白介导类风湿关节炎发病机制的初步研究[J].中华风湿病学杂志,2006,10(5):261-264. 被引量:13
  • 3吴庆军,曾小峰,唐福林,张奉春,董怡,赵岩,田新平,史艳萍,张乃峥.类风湿关节炎早期诊断的血清学研究和临床应用[J].医学研究杂志,2006,35(5):43-44. 被引量:27
  • 4刘琼,李向培.骨桥蛋白在类风湿关节炎发病机制中的作用[J].中华风湿病学杂志,2007,11(2):109-111. 被引量:5
  • 5萨姆布鲁克J 拉塞尔DW著 黄培堂 译.分子克隆实验指南[M].北京:科学出版社,2002.481-482.
  • 6陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:775.
  • 7Machold KP, Stamm TA, Nell VP, et al. Very recent onset rheu- matoid arthritis:clinical and serological patient characteristics as- sociated with radiographic progression over the first years of dis- ease. Rheumatology ( Oxford), 2007,46 ( 2 ) : 329 -342.
  • 8Arnett FG, Edworthy SM, Bloch DA, et al. The American Rheu- matoid Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum,1988,31 (3) :315-324.
  • 9Steinbrecker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc, 1949, 140 ( 8 ) : 659- 662.
  • 10Kazakova M,Batalov A, Deneva T, et al. Relationship between sono- graphic parameters and YKL-40 levels in rheumatoid arthritis. Rheu- matol Int,2012,28(168) :505-508.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部